findmyKOL
Clinical trialNCT01214083CompletedPhase 2Interventional

N-acetylcysteine Plus Naltrexone for the Treatment of Alcohol Dependence

SponsorVA Office of Research and DevelopmentEnrollment111Alcoholism
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Gihyun Yoon, MD

    VA Connecticut Healthcare System West Haven Campus, West Haven, CT

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Va Connecticut Healthcare System West Haven Campus, West Haven, Ct

    West Haven, Connecticut, United States

  • Minneapolis Va Health Care System, Minneapolis, Mn

    Minneapolis, Minnesota, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 Oct 2010
Primary completion
30 Sept 2015
Completion
30 Oct 2016
Last update posted
8 Apr 2020
Registered enrollment
111
Registry id
NCT01214083

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.